Wall Street Analysts Think Immunovant (IMVT) Could Surge 68.63%: Read This Before Placing a Bet

Shares of Immunovant, Inc. (IMVT) have gained 0.1% over the past four weeks to close the last trading session at $29.39, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $49.56 indicates a potential upside of 68.6%. The average comprises 16 short-term price targets ranging from a low of $32 to a high of $57, with a standard deviation of $6.11. While the lowest estimate indicates ...